% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{DAzorn:305229,
author = {D. D Azorín$^*$ and D. C. F. Hoffmann$^*$ and N.
Hebach$^*$ and E. Jung$^*$ and D. Hausmann$^*$ and M.
Ratliff$^*$ and L. Hai$^*$ and S. Horschitz and A. Jabali
and M. Osswald$^*$ and M. A. Karreman$^*$ and T. Kessler$^*$
and S. Wendler$^*$ and C. D. Mayer$^*$ and C. Löb$^*$ and
P. Lehnert$^*$ and G. M. Cebulla$^*$ and D. Reibold$^*$ and
R. Khajuria$^*$ and P. Bordignon and A. E. Moor and T.
Holland-Letz$^*$ and J. Reckless and N. Ramsden and D.
Grainger and A. Kreshuk and P. Koch and W. Wick$^*$ and S.
Heuer$^*$ and F. Winkler$^*$},
title = {{S}creening for {T}umor {M}icrotube-{T}argeting {D}rugs
{I}dentifies {PKC} {M}odulators as {M}ultipotent
{I}nhibitors of {G}lioblastoma {P}rogression.},
journal = {Cancer discovery},
volume = {nn},
issn = {2159-8274},
address = {Philadelphia, Pa.},
publisher = {[Verlag nicht ermittelbar]},
reportid = {DKFZ-2025-02075},
pages = {nn},
year = {2025},
note = {#EA:B320#LA:B320# / epub},
abstract = {Glioblastomas are incurable primary brain tumors that
depend on neural-like cellular processes, tumor microtubes
(TMs), to invade the brain. TMs also interconnect single
tumor cells to a communicating multicellular network that
resists current therapies. Here, we developed a combined,
comprehensive in vitro/in vivo anti-TM drug screening
approach, including machine-learning-based analysis tools.
Two Protein Kinase C (PKC) modulators robustly inhibited TM
formation and pacemaker tumor cell-driven, TM-mediated
glioblastoma cell network communication. Since
TM-unconnected tumor cells exhibited increased sensitivity
to cytotoxic therapy, the PKC activator TPPB was combined
with radiotherapy, and long-term intravital 2-photon
microscopy paired with spatially resolved multiomics
revealed anti-TM and anti-tumor effects. TPPB treatment also
decreased the expression of tweety family member 1 (TTYH1),
a key driver of invasive TMs. Our study establishes a novel
screening pipeline for anti-TM drug development, identifies
a TM master regulator pathway, and supports the approach of
TM targeting for efficient brain tumor therapies.},
cin = {B320 / HD01 / C060},
ddc = {610},
cid = {I:(DE-He78)B320-20160331 / I:(DE-He78)HD01-20160331 /
I:(DE-He78)C060-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41065276},
doi = {10.1158/2159-8290.CD-24-0414},
url = {https://inrepo02.dkfz.de/record/305229},
}